Stacey L. Berg, MD
Department or Service
Location
- Texas Medical Center
Specialty
Phone: 832-824-4588
Contact Information
Research Area
- Developmental therapeutics
Director, Palliative Care Program
Director, Developmental Therapeutics Program
Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine
Education
| School | Education | Degree | Year |
|---|---|---|---|
| NIH/NCI | fellowship | Pediatric Hematology Oncology | 1994 |
| University of Pittsburgh School of Medicine | residency | Pediatrics | 1988 |
| University of Pittsburgh School of Medicine | internship | Pediatrics | 1986 |
| University of Pittsburgh School of Medicine | medical school | Doctor of Medicine | 1985 |
About
Dr. Stacey Berg is a pediatric oncologist specializing in the development of new anticancer drugs for children. She also has a strong interest in clinical trial design, biomedical ethics, and the incorporation of palliative care principles into pediatric oncology practice.
Organization
| Organization Name | Role |
|---|---|
| American Academy of Hospice and Palliative Medicine | Member |
| American Academy of Pediatrics (AAP) | Member |
| American Association for Cancer Research (AACR) | Member |
| American Society Clinical Oncology (ASCO) | Member |
| Children's Oncology Group (COG) | Developmental Therapeutics Steering Committee |
Research Statement
Dr. Stacey Berg’s primary research interest is in the design and conduct of early phase clinical trials of new anticancer agents. This process includes the evaluation of new agents against pediatric cancer targets in the laboratory, as well as preclinical pharmacokinetic studies. With these data, phase 1 studies are designed to determine the appropriate dose and schedule of new agents for use in children, as well as to obtain preliminary indications of activity. These results form the basis of subsequent larger scale clinical trials.
Selected Publications
Related Videos
-
Relapse & Developmental Therapeutics -
Medically Speaking: Cancer Clinical Trials, Stacey L. Berg, MD